homocysteine has been researched along with oxcarbazepine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Badiou, S; Breton, H; Charasson, V; Crespel, A; Cristol, JP; Gelisse, P; Hillaire-Buys, D; Peyriere, H | 1 |
Kurul, S; Unalp, A; Yiş, U | 1 |
Arga, M; Arhan, E; Biberoglu, G; Cansu, A; Emeksiz, HC; Gulbahar, O; Hasanoglu, A; Serdaroglu, A | 1 |
Kim, DW; Kim, JH; Lee, SY; Shon, YM | 1 |
Abdulahi Abdurahman, A; Djafarian, K; Rezaei, S; Shab-Bidar, S | 1 |
1 review(s) available for homocysteine and oxcarbazepine
Article | Year |
---|---|
Oxcarbazepine administration and the serum levels of homocysteine, vitamin B12 and folate in epileptic patients: A systematic review and meta-analysis.
Topics: Anticonvulsants; Carbamazepine; Epilepsy; Folic Acid; Homocysteine; Humans; Oxcarbazepine; Vitamin B 12 | 2017 |
1 trial(s) available for homocysteine and oxcarbazepine
Article | Year |
---|---|
Comparison of carbamazepine and oxcarbazepine effects on aminothiol levels.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Cysteine; Dipeptides; Epilepsy; Female; Homocysteine; Humans; Male; Middle Aged; Oxcarbazepine; Risk Factors | 2008 |
3 other study(ies) available for homocysteine and oxcarbazepine
Article | Year |
---|---|
Homocysteine levels in epileptic children receiving antiepileptic drugs.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Epilepsy; Female; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Male; Oxcarbazepine; Valproic Acid; Vitamin B 12 | 2007 |
Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs.
Topics: Adolescent; Anticonvulsants; Arginine; Atherosclerosis; Biomarkers; Carbamazepine; Child; Epilepsy; Female; Homocysteine; Humans; Male; Nitric Oxide; Oxcarbazepine; Prospective Studies; Risk Factors; Valproic Acid | 2013 |
Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Biomarkers; Carbamazepine; Cholesterol, LDL; Epilepsy; Female; Fructose; Homocysteine; Humans; Levetiracetam; Male; Oxcarbazepine; Piracetam; Prospective Studies; Risk Factors; Topiramate | 2013 |